This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vaziri, N. D. Articles by Ding, Y. Search for Related Content PubMed PubMed Citation Articles by Vaziri, N. D. Articles by Ding, Y. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB LEAD, ELEMENTAL NITRIC OXIDE Related Collections Pathophysiology Cell biology/structural biology Other hypertension Hypertension - basic studies Coronary circulation Endothelium/vascular type/nitric oxide Mechanism of atherosclerosis/growth factors

(Hypertension. 2001;37:223.)
© 2001 American Heart Association, Inc.

Scientific Contributions

Effect of Lead on Nitric Oxide Synthase Expression in Coronary Endothelial Cells

Role of Superoxide

Nosratola D. Vaziri; Yaoxian Ding

From the Division of Nephrology and Hypertension, Department of Medicine, University of California, Irvine.

Correspondence to N.D. Vaziri, MD, MACP, Division of Nephrology and Hypertension, UCI Medical Center, 101 The City Drive, Orange, CA 92868. E-mail ndvaziri{at}uci.edu

Chronic exposure to low levels of lead causes hypertension (HTN) in humans and animals. We have previously shown that increased reactive oxygen species (ROS) leads to enhanced NO inactivation, depressed NO bioavailability, and compensatory upregulation of NO synthases (NOSs) in rats with lead-induced HTN. We have further demonstrated increased ROS generation with lead exposure in cultured endothelial cells. In the present study, we tested the effect of lead (medium containing lead acetate, 1 ppm) alone and with either the superoxide dismutase–mimetic agent tempol or a potent antioxidant lazaroid compound (both at 10^-8 and 10^-7 mol/L) on endothelial NOS expression and NO production in cultured human coronary endothelial cells. Lead-treated cells showed a significant upregulation of endothelial NOS (eNOS) protein abundance (P<0.002) and a significant increase in the production of NO metabolites (NO₂^- +NO₃^-=NOx, P<0.01). Cotreatment with either tempol or lazaroid abrogated the lead-induced upregulation of eNOS protein and NO_x production. In contrast, tempol and lazaroid had no effect on either eNOS protein expression or NO_x production in the control cells. Thus, lead exposure upregulated eNOS expression in vitro, simulating the results of our previous in vivo studies. This phenomenon points to a direct as opposed to an indirect (eg, HTN-mediated) effect of lead on NO metabolism. The reversal of lead effect by lazaroid and the cell-permeable superoxide dismutase–mimetic agent tempol suggests that lead exposure increases generation and/or reduces dismutation of superoxide, which in turn promotes oxidative stress, enhances NO inactivation, and elicits a compensatory upregulation of eNOS whose expression is negatively regulated by NO.

Key Words: lead • blood pressure • endothelium • free radicals • nitric oxide • arteries

This article has been cited by other articles:

				S. Nambiar, S. Viswanathan, B. Zachariah, N. Hanumanthappa, and Sridhar Gopalakrishna Magadi Oxidative Stress in Prehypertension: Rationale for Antioxidant Clinical Trials Angiology, April 1, 2009; 60(2): 221 - 234. [Abstract] [PDF]

				C. S. Wilcox and A. Pearlman Chemistry and Antihypertensive Effects of Tempol and Other Nitroxides Pharmacol. Rev., December 1, 2008; 60(4): 418 - 469. [Abstract] [Full Text] [PDF]

				N. D. Vaziri Mechanisms of lead-induced hypertension and cardiovascular disease Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H454 - H465. [Abstract] [Full Text] [PDF]

				I. Dublineau, L. Grandcolas, S. Grison, C. Baudelin, F. Paquet, P. Voisin, J. Aigueperse, and P. Gourmelon Modifications of Inflammatory Pathways in Rat Intestine Following Chronic Ingestion of Depleted Uranium Toxicol. Sci., August 1, 2007; 98(2): 458 - 468. [Abstract] [Full Text] [PDF]

				C. S. Wilcox Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R913 - R935. [Abstract] [Full Text] [PDF]

				S. Kasperczyk, E. Birkner, A. Kasperczyk, and J. Kasperczyk Lipids, lipid peroxidation and 7-ketocholesterol in workers exposed to lead Human and Experimental Toxicology, June 1, 2005; 24(6): 287 - 295. [Abstract] [PDF]

				N. D. Vaziri, Y. Ding, Z. Ni, and C. H. Barton Bradykinin Down-Regulates, Whereas Arginine Analogs Up-Regulates, Endothelial Nitric-Oxide Synthase Expression in Coronary Endothelial Cells J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 121 - 126. [Abstract] [Full Text] [PDF]

				E. Courtois, M. Marques, A. Barrientos, S. Casado, and A. Lopez-Farre Lead-Induced Downregulation of Soluble Guanylate Cyclase in Isolated Rat Aortic Segments Mediated by Reactive Oxygen Species and Cyclooxygenase-2 J. Am. Soc. Nephrol., June 1, 2003; 14(6): 1464 - 1470. [Abstract] [Full Text] [PDF]

				M.-L. Si and T. J.-F. Lee Pb2+ Inhibition of Sympathetic {alpha}7-Nicotinic Acetylcholine Receptor-Mediated Nitrergic Neurogenic Dilation in Porcine Basilar Arteries J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1124 - 1131. [Abstract] [Full Text] [PDF]

				M. Marques, I. Millas, A. Jimenez, E. Garcia-Colis, J. A. Rodriguez-Feo, S. Velasco, A. Barrientos, S. Casado, and A. Lopez-Farre Alteration of the Soluble Guanylate Cyclase System in the Vascular Wall of Lead-Induced Hypertension in Rats J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2594 - 2600. [Abstract] [Full Text] [PDF]

				N. D. Vaziri, Y. Ding, and Z. Ni Compensatory Up-Regulation of Nitric-Oxide Synthase Isoforms in Lead-Induced Hypertension; Reversal by a Superoxide Dismutase-Mimetic Drug J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 679 - 685. [Abstract] [Full Text] [PDF]